GE HealthCare Highlights Commitment to Delivering Better Patient Experiences and Outcomes Through Deep Learning at RSNA 2023
November 29 2023 - 9:00AM
Business Wire
GE HealthCare is proud to announce the addition
of True Enhance DL to its Effortless Recon DL portfolio
Through its leading imaging solutions and commitment to
innovation, GE HealthCare (NASDAQ: GEHC) remains at the forefront
of leveraging deep learning, a subset of artificial intelligence
(AI), to benefit a multitude of clinicians and patients. True
Enhance DLi for CT is the latest addition to GE HealthCare’s
growing Effortless Recon DL portfolio of deep learning-based
solutions – which also includes AIR Recon DL for MR and PET/MR,
Sonic DL for MR, TrueFidelity DL for CT, Precision DL for PET/CT,
and Helix for X-ray – with the goal of improving image quality and
helping to better inform clinical decision-making for improved
patient outcomes.
When diagnosing patients in areas where every second counts,
like neurology, oncology and cardiology, clinicians need fast,
clear and reliable imaging technologies. GE HealthCare is committed
to using deep learning to accelerate and improve diagnostics
through efficient workflows and faster exam times. These
technologies have benefited millions of patients globally.
“The potential of deep learning to create more efficient
workflows and allow more patients to receive essential medical
imaging services without compromising quality is boundless,” said
Jan Makela, President & CEO of Imaging at GE HealthCare. “GE
HealthCare aims to address critical challenges in the imaging field
such as workflow inefficiencies, staff burnout and shortages, and
the need for broader access to state-of-the-art imaging. We’re
proud to be at the forefront of deep learning integration and to
share our Effortless Recon DL portfolio of solutions driven by this
game-changing technology at RSNA 2023.”
Innovations from GE HealthCare in molecular imaging and computed
tomography (MICT), magnetic resonance (MR) and x-ray that leverage
deep learning are making state-of-the-art imaging accessible to
healthcare practices and their patients across multiple care areas.
These include:
- True Enhance DLii uses a
dedicated Deep Neural Network (DNN) designed to generate deep
learning-based monochromatic-like images from single-energy X-ray.
It is designed to enhance contrast resolution for confident
diagnosis, especially for challenging oncology cases or pulmonary
embolism evaluation. The AI-based solution aims to provide
clinicians a simple workflow and incredible image quality without a
radiation penalty.
- TrueFidelity DL is
available across the company’s Revolution Apex and Revolution
Ascend platforms, leveraging a DNN to generate high-definition,
low-noise CT images with exceptional sharpness, low-contrast image
quality with preferred noise textureiii, at the same dose.iv GE
HealthCare is also excited to expand TrueFidelity DL to lung and
extremity at this year’s show. Exclusively available on Revolution
Apex platform, these new features enable high resolution imaging to
increase visual sharpness with reduced noise for confident
reporting and accepted image texture.
- Precision DL is a deep
learning-based image processing software designed to enhance image
quality in PET/CT scans, providing clinicians with a powerful tool
to aid in precise diagnoses and treatment planning with the image
quality performance benefits typically associated with
hardware-based Time of Flight (ToF) reconstruction, including
improved contrast-to-noise ratio, contrast recovery,v and
quantitative accuracy.vi
- AIR Recon DL is a
pioneering deep-learning image reconstruction technique that helps
improve image sharpness and enables reduced exam times by up to 50%
without compromising image qualityvii. These features help to
enhance workflow efficiency and productivity for healthcare
professionals, reduce the need for repeat scans, enable faster
diagnoses, and enhance patient experience. With expansion from 2D
to 3D and PROPELLER imaging sequences, AIR Recon DL expands
to nearly all MRI clinical procedures, covering all anatomies. AIR
Recon DL has been used by an estimated 16 million patients
worldwide to date.viii
- Sonic DL is a deep learning
breakthrough designed to accelerate MRI exams. For cardiac imaging,
Sonic DL has the ability to acquire high-quality MR images up to 12
times faster than conventional methods, enabling cardiac imaging
within a single heartbeat.ix
- Helix Advanced Image
Processing is an innovation in X-ray technology that
revolutionizes diagnostic imaging quality by consistently
delivering images with appropriate detail, contrast, and latitude
to enable radiologists to visualize key clinical details.
For more information on GE HealthCare and these innovative
solutions at RSNA, visit Booth 7326 or the RSNA 2023 events
page.
About GE HealthCare Technologies Inc.
GE HealthCare is a leading global medical technology,
pharmaceutical diagnostics, and digital solutions innovator,
dedicated to providing integrated solutions, services, and data
analytics to make hospitals more efficient, clinicians more
effective, therapies more precise, and patients healthier and
happier. Serving patients and providers for more than 100 years, GE
HealthCare is advancing personalized, connected, and compassionate
care, while simplifying the patient’s journey across the care
pathway. Together our Imaging, Ultrasound, Patient Care Solutions,
and Pharmaceutical Diagnostics businesses help improve patient care
from diagnosis, to therapy, to monitoring. We are an $18.3 billion
business with 50,000 employees working to create a world where
healthcare has no limits.
Follow us on Facebook, LinkedIn, Twitter, Instagram, and
Insights for the latest news, or visit our website
https://www.gehealthcare.com/ for more information.
____________________ i True Enhance DL is 510(k)-pending with
the U.S. FDA. Not available for sale in the United States ii True
Enhance DL is 510(k)-pending with the U.S. FDA. Not available for
sale in the United States iii As demonstrated in a clinical
evaluation consisting of 40 cases and 6 physicians, where each case
was reconstructed with both DLIR and ASiR-V and evaluated by 3 of
the physicians. In 92% of the reads, DLIR’s noise texture was rated
better than ASiR-V’s. This rating was based on each individual
reader’s preference. iv Image quality comparisons were evaluated by
phantom tests of MTF, SSP, axial NPS, standard deviation of image
noise, CT Number accuracy, CNR, and artifact analysis.
Additionally, LCD was demonstrated in phantom testing using a model
observer with the head and body MITA CT IQ Phantoms (CT191, CT189
The Phantom Laboratory). DLIR-H and ASiR-V reconstructions were
performed using the same raw data. v Precision DL with Omni Legend
32cm data improves Contrast Recovery (CR) by 11% on average and
Contrast-to-Noise Ratio (CNR) by average of 23% as compared to
non-ToF reconstruction. CR and CNR demonstrated using clinical data
with inserted lesions of known size, location, and contrast. Using
data from Omni Legend 32 cm, CR and CNR were measured using High
Precision DL and QCHD. vi Precision DL with Omni Legend 32cm
improves feature quantitation accuracy by 14% as compared to
Discovery MI with ToF reconstruction, at comparable noise level.
Quantitation accuracy demonstrated using clinical data with
inserted lesions of known size, location, and contrast (ground
truth). Feature SUVmean from Omni Legend 32 cm with High Precision
DL compared to SUVmean from Discovery MI 25 cm with QCFX. vii GE
HealthCare Data on File viii calculated by IB data with estimation
20 scans per day, 5.5 working day in a week, fully start using AIR™
Recon DL 4 weeks after delivery, as of Oct 31, 2023. ix GE
HealthCare Data on File
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231128359385/en/
Maureen Oladipo Global Communications Director, Magnetic
Resonance M 229.418.4479 maureen.oladipo@ge.com
GE HealthCare Technologies (NASDAQ:GEHC)
Historical Stock Chart
From Jun 2024 to Jul 2024
GE HealthCare Technologies (NASDAQ:GEHC)
Historical Stock Chart
From Jul 2023 to Jul 2024